Acetaminophen modulation of hydrocodone reward in rats

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 3, 2011, Pages 307-310

  Nazarian, Arbi ^a   Are, Deepthi ^a   Tenayuca, John M ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Acetaminophen; Conditioned place preference; Drug abuse; Hydrocodone; Prescription opioid analgesics; Reward

Indexed keywords

HYDROCODONE; PARACETAMOL;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; LOCOMOTION; MALE; MODULATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

ACETAMINOPHEN; ANIMALS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROCODONE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REWARD;

RATTUS;

EID: 79957666839     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.05.003     Document Type: Article

References (30)

1. Abbott FV, Hellemans KG. Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects. Behav Brain Res 2000;112:177-86.
2. Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth 2008;18:915-21.
3. Bardo MT, Rowlett JK, Harris MJ. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 1995;19:39-51.
4. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997;277:1094-7. (Pubitemid 27371630)
5. Bonnefont J, Alloui A, Chapuy E, Clottes E, Eschalier A. Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism. Anesthesiology 2003;99:976-81. (Pubitemid 37186091)
6. Boutaud O, Aronoff DM, Richardson JH, Marnett LJ, Oates JA. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases. Proc Natl Acad Sci USA 2002;99:7130-5.
7. Dasgupta N, Kramer ED, Zalman MA, et al. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend 2006;82:135-42.
8. De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 2000;483:52-6.
9. Finlay JM, Jakubovic A, Phillips AG, Fibiger HC. Fentanyl-induced conditional place preference: lack of associated conditional neurochemical events. Psychopharmacology Berl 1988;96:534-40. (Pubitemid 19002232)
10. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004;28:176-88.
11. Hama AT, Sagen J. Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain. Neuropharmacology. 2010;58:758-66.
12. Hogestatt ED, Jonsson BA, Ermund A, Andersson DA, Bjork H, Alexander JP, et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem. 2005;280:31405-12. (Pubitemid 41291881)
13. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national results on adolescent drug use: overview of key findings, 2007. NIH Publication No 08-6418 National Institute on Drug Abuse, Bethesda, MD; 2008.
14. Katz NP, Adams EH, Benneyan JC, et al. Foundations of opioid risk management. Clin J Pain 2007;23:103-18. (Pubitemid 46145457)
15. Mallet C, Daulhac L, Bonnefont J, et al. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain 2008;139:190-200.
16. Mallet C, Barriere DA, Ermund A, Jonsson BA, Eschalier A, Zygmunt PM, et al. TRPV1 in brain is involved in acetaminophen-induced antinociception. PLoS One 2010;5.
17. Marinelli S, Pascucci T, Bernardi G, Puglisi-Allegra S, Mercuri NB. Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology 2005;30:864-70. (Pubitemid 40570902)
18. McBride WJ, Murphy JM, Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 1999;101:129-52. (Pubitemid 29236359)
19. Meert TF, Vermeirsch HA. A preclinical comparison between different opioids: antinociceptive versus adverse effects. Pharmacol Biochem Behav. 2005;80:309-26. (Pubitemid 40170428)
20. Nagakura Y, Okada M, Kohara A, et al. Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J Pharmacol Exp Ther 2003;306:490-7. (Pubitemid 36886145)
21. Peckham EM, Traynor JR. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J Pharmacol Exp Ther 2006;316:1195-201. (Pubitemid 43345294)
22. Randall CK, Kraemer PJ, Bardo MT. Morphine-induced conditioned place preference in preweanling and adult rats. Pharmacol Biochem Behav 1998;60:217-22. (Pubitemid 28236633)
23. Ruggieri V, Vitale G, Pini LA, Sandrini M. Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol. Naunyn Schmiedebergs Arch Pharmacol 2008;377:219-29.
24. SAMHSA. (Substance Abuse and Mental Health Services Administration), office of applied studies. Results from the 2007 National Survey on Drug Use and Health: National Findings; 2008.
25. SAMHSA. (Substance Abuse and Mental Health Administration), office of applied studies. Treatment Episode Data Set (TEDS): 1996-2006, National Administration to Substance Abuse Treatment Services; 2008.
26. Sandrini M, Vitale G, Ottani A, Pini LA. The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain. Inflamm Res. 1999;48:120-7. (Pubitemid 29137661)
27. SDI/Verispan. Top 200 generic drugs by total prescriptions. http://drugtopics.modernmedicine.com/top200gen2008.Last accessed, March 20, 2011. Drug Topics2008.
28. Solinas M, Justinova Z, Goldberg SR, Tanda G. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J Neurochem 2006;98:408-19. (Pubitemid 44133146)
29. Steinpreis RE, Rutell AL, Parrett FA. Methadone produces conditioned place preference in the rat. Pharmacol Biochem Behav 1996;54:339-41. (Pubitemid 26180169)
30. Zygmunt PM, Chuang H, Movahed P, Julius D, Hogestatt ED. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 2000;396:39-42.